InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: D theG post# 10182

Wednesday, 02/07/2018 9:57:05 AM

Wednesday, February 07, 2018 9:57:05 AM

Post# of 44784
Here are the milestones from last January. Since DD is not your thing. You think Zami was truthful?

Data readout does selection ARS 1H17
Contract with U.S. Government for ARS 2H17
Initiation of pivotal study ARS NHP 2H17
Data readout phase 1 open label HCT 2H17
Preclinical data Fukushima 1H17
Preclinical data NYBC 1H17
U.S/Europe phase 3 study initiation 1Q17
Japan pivitol study initiation 2H17
Closing on JV deal with Sosei 1Q17
Data from IC multinational phase 2 early 2018
Interim results from Europe phase 3 CLI 2H18-1H19

And at the bottom with milestones for 12 months a couple more.

Initially trial hip fracture
Licensing deal JV with China.

Misses on vast majority of them. Some by 7 months now. So why the delay on preclinical data from Fukushima and NYBC. Having trouble enrolling mice?

But I'm ok with management.